rdcjournalRoyal Dental College JournalE-Volume 8 Issue 1MultidisciplinaryEnglishJanuary- DecemberNNY20250625BiochemistryFenugreek Galactomannan: A Potential Therapeutic Approach for Diabetes ManagementEnglishY3941BinithaPP1EnglishN10.67091/JRDC.2025.8108Diabetes mellitus is a prevalent chronic disorder characterized by elevated blood glucose levels resulting from inadequate insulin production or utilization. The rising global incidence, particularly in developing countries, underscores the urgent need for alternative therapeutic options beyond conventional treatments, which often have undesirable side effects and high costs. Natural plant-based remedies, such as fenugreek (Trigon Ella foenum-graecum L), have garnered attention due to their promising glycemic control properties. Rich in dietary fibers, phytochemicals, and bioactive compounds including galactomannan, fenugreek exhibits multifaceted therapeutic effects, including anti-diabetic, anti-inflammatory, and antioxidant activities. The primary mechanisms involve delaying gastric emptying, inhibiting carbohydrate absorption, and enhancing insulin secretion and sensitivity. Preclinical studies in rodents demonstrate fenugreek’s capacity to improve blood glucose and lipid profiles, alongside promoting beneficial modulation of gut microbiota. Human trials suggest that fenugreek’s soluble fiber, particularly galactomannan, significantly lowers fasting blood glucose levels. However, despite encouraging results, most evidence remains from animal models, and comprehensive clinical trials are needed to establish optimal dosages, long-term safety, and mechanisms of action conclusively. Understanding fenugreek’s therapeutic potential could provide a cost-effective, natural adjunct or alternative to existing anti-diabetic medications, contributing to better management of blood glucose and reducing diabetic complications. Continued research and standardized human studies are essential to transitioning fenugreek-based therapies from experimental to mainstream clinical use.EnglishBlood glucose levels, Diabetes mellitus, Fenugreek seeds, Natural alternativeshttps://www.rdcjournal.org/abstract?id=303References16191. Magliano DJ, Boyko EJ, Atlas ID. What is diabetes? In: IDF Diabetes Atlas. 10th edition. International Diabetes Federation; 2021;54-61. 2.Leiherer A, Mundlein A, Drexel H. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vasc Pharmacol. 2013;58(3):3and;ndash;20. doi 10.1016/j.vph.2012.09.002. 3. Meghwal M, Goswami TK. A review on the functional properties, nutritional content, medicinal utilization, and potential application of fenugreek. J Food Process Technol. 2012;3(1):1-10. doi:10.4172/2157- 7110.1000181. 4.Aasim M, Baloch FS, Nadeem MA, Bakhsh A. Fenugreek (Trigonella foenum-graecum L.): An underutilized edible plant of the modern world. In: Global Perspectives on Underutilized Crops. Cham: Springer; 2018. p. 381and;ndash;408. doi:10.1007/978-3-319-77776-4_12. 5.Rao PU, Sesikeran B, Rao PS, Naidu NN, Rao VV, Ramachandran EP. Short-term nutritional and safety evaluation of fenugreek. Nutr Res. 1996;16:1495and;ndash;505. doi.org/10.1016/0271-5317(96)00163-7. 6.Raghuram TC, Sharma RD, Sivakumar B. Effect of fenugreek seeds on intravenous glucose disposition in non-insulin dependent diabetic patients. Phytother Res.1994;8(2):83-86. doi.org/10.1002/ptr.2650080206. 7.Gonda S, Szűcs Z, Plaszkand;oacute; T, Cziaky Z, Kiss-Szikszai A, Sinka D et al. Quality-controlled LC-ESI-MS food metabolomics of fenugreek (Trigonella foenum-graecum) sprouts: Insights into changes in primary and specialized metabolites. Food Res Int. 2023;164:112347.doi.org/10.1016/j.foodres.2022.112347. 8.Faisal Z, Irfan R, Akram N, Manzoor HMI, Aabdi MA, Anwar MJ et al. The multifaceted potential of fenugreek seeds: From health benefits to food and nanotechnology applications. Food Sci Nutr. 2024;12:2294and;ndash;2310. doi: 10.1002/fsn3.3959. 9.Yao D, Zhang B, Zhu J, Zhang Q, Hu Y, Wang S et al. Advances on application of fenugreek seeds as functional foods: Pharmacology, clinical application, products, patents, and market. Crit Rev Food Sci Nutr. 2020 Jan;60(14):23422352.doi 10.1080/10408398.2019.1635567. 10. Kumar P, Bhandari U, Jamadagni S. Fenugreek seed extract inhibits fat accumulation and ameliorates dyslipidemia in high-fat diet-induced obese rats. Biomed Res Int. 2014;2014:606021. doi: 10.1155/2014/606021. 11. Luo W, Deng J, He J, Yin L, You R, Zhang L, et al. Integration of molecular docking, molecular dynamics, and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes. J Cell Mol Med. 2023; 27:1959and;ndash;1974. doi:10.1111/jcmm.17787. 12.Knott EJ, Richard AJ, Mynatt RL, Ribnicky DM, Stephens JM, Bruce-Keller A. Fenugreek supplementation during high-fat feeding improves specific markers of metabolic health. Sci Rep. 2017;7:12770. doi.org/10.1038/s41598-017-12846-x 13.Bruce-Keller AJ, Richard AJ, Fernandez-Kim SO, Ribnicky DM, Salbaum JM, Carmouche R et al. Fenugreek counters the effects of high-fat diet on gut microbiota in mice: Links to metabolic benefit. Sci Rep. 2020;10:1245. doi.org/10.1038/s41598-020- 58005-7. 14.Shtriker MG, Hahn M, Taieb E, Nyska A, Moallem U, Tirosh O et al. Fenugreek galactomannan and citrus pectin improve several parameters associated with glucose metabolism and modulate gut microbiota in mice. Nutrition. 2018;46:134and;ndash;142.e3. doi: 10.1016/j.nut.2017.07.012. 15.Evans AJ, Hood RL, Oakenfull DG, Sidhu GS. Relationship between structure and function of dietary fibre: a comparative study of the effects of three galactomannans on cholesterol metabolism in the rat. Br J Nutr. 1992 Jul;68(1):217-29. doi: 10.1079/bjn19920079.